Mydecine Innovations Group Inc. (MYCO.NE)
| Previous Close | 0.8400 |
| Open | 0.9500 |
| Bid | 1.0100 x N/A |
| Ask | 1.1400 x N/A |
| Day's Range | 0.8600 - 1.1500 |
| 52 Week Range | 0.8400 - 30.0000 |
| Volume | |
| Avg. Volume | 39,124 |
| Market Cap | 274.489M |
| Beta (5Y Monthly) | 4.06 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
- CNW Group
Mydecine Announces Size of Previously Announced Overnight Marketed Public Offering of Units
Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO: MYCO) (OTC:M YCOF) (FSE: 0NFA) is pleased to announce today that pursuant to its previously announced best efforts overnight marketed offering (the "Offering"), the Company will issue up to 3,478,260 units of the Company (the "Units") at a price of $1.15 per Unit (the "Issue Price") for aggregate gross proceeds of up to $4 million.
- CNW Group
Mydecine Overnight Marketed Public Offering of Units
Mydecine Innovations Group Inc. ("Mydecine" or the "Company") (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) is pleased to announce that it has commenced an overnight marketed public offering (the "Offering") of units of the Company (the "Units") at a price of $1.15 per Unit (the "Issue Price"). The size of the Offering will be determined in the context of the market.
